#011: The Chime IPO is Near, Hinge Health, MNTN, Perplexity, Rippling, and Addepar
This page contains links to our partners. We may be compensated when a link is clicked. Read the disclosures to learn more.
The Chime IPO date will be in mid-June. Craig goes over the initial filing and business highlights.
The Hinge Health IPO and MNTN IPO are Thursday, May 22nd, and will trade on the NYSE. Are IPOs back?
In IPO Radar News, Rippling, Perplexity, and Addepar have all raised news funds, and valuations continue to rise.
Navan and Figma have hired banks for their IPOs. Apple is partnering with an IPO radar company to support brain-computer interfaces on its devices.
This video is for informational purposes only. Mentions are not a recommendation to buy or sell any pre-IPO or public company. Invest in IPOs and private companies at your own risk.
0:00 Intro
0:44 eToro IPO
1:44 Hinge Health IPO
2:52 MNTN IPO
3:05 Ryan Reynolds MNTN
4:12 Are IPOs Back?
5:05 Chime IPO Filing
5:39 Chime Founder Story
6:20 Chime is Not a Bank
8:12 IPO Timing
9:08 Secondary Valuation
9:45 IPO Access
11:50 Chime S-1 Highlights
14:28 Chime IPO Summary
15:44 IPO Radar News
16:20 Rippling Raise
17:25 Rippling IPO “Not Imminent”
18:51 Addepar Raise
20:24 Addepar Name Meaning
21:06 Perplexity Raise
21:24 Perplexity Search Demo
22:15 Perplexity Growth
22:58 Perplexity Publicity
24:45 Navan IPO Potential
25:54 Figma Hires Morgan Stanley
26:41 Apple and Synchron Partnership
28:32 Support the Show
30:32 Outro
Craig Stephens is a former IT professional who left his 19-year consulting career at the IRS to be a full-time finance writer. He started Access IPOs in 2016 to provide a resource for ordinary investors pursuing investment access to IPOs and pre-IPO startups. Craig studied Finance at Michigan State University and lives in Northern Virginia with his wife and three children. Learn more about Craig.
* This is a testimonial in partnership with Fundrise, Hiive, and other affiliate partners. We earn a commission from partner links on AccessIPOs.com. All opinions are my own. If you sign up with one of our partners through certain on this website, Access IPOs will be compensated at no additional cost to the reader. See the full disclosure here. Risk Statement: Investing in IPOs and pre-IPO startups involves significant risk. Do not invest in companies based solely on what is included in this article. Only invest in IPOs and pre-IPO companies with money you can afford to lose. Access IPOs is for informational purposes only. Mentions of specific investments should not be construed as financial advice. Conduct personalized research and consider consulting with an investment advisor before investing.
